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Abstract: Mycobacterium paratuberculosis has
been suggested to be involved in the pathogenesis
of Crohn’s disease (CD). The importance of micro-
organisms in CD is supported by the association of
CD with mutations in the intracellular pathogen
recognition receptor (PRR) nucleotide-binding oli-
gomerization domain 2 (NOD2). The aim of this
study is to investigate the PRR involved in the
recognition of M. paratuberculosis. Methods used
include in vitro stimulation of transfected cell lines,
murine macrophages, and human PBMC. M. para-
tuberculosis stimulated human TLR2 (hTLR2)-Chi-
nese hamster ovary (CHO) cells predominantly and
hTLR4-CHO cells modestly. Macrophages from
TLR2 and TLR4 knockout mice produced less cy-
tokines compared with controls after stimulation
with M. paratuberculosis. TLR4 inhibition in hu-
man PBMC reduced cytokine production only af-
ter stimulation with live M. paratuberculosis. TLR-
induced TNF-, IL-1, and IL-10 production is
mediated through MyD88, whereas Toll-IL-1R do-
main-containing adaptor inducing IFN- (TRIF)
promoted the release of IL-1. hNOD2-human
embryo kidney (HEK) cells, but not hNOD1-HEK
cells, responded to stimulation with M. paratuber-
culosis. PBMC of individuals homozygous for the
3020insC NOD2 mutation showed a 70% defec-
tive cytokine response after stimulation with M.
paratuberculosis. These results demonstrate that
TLR2, TLR4, and NOD2 are involved in the rec-
ognition of M. paratuberculosis by the innate im-
mune system. J. Leukoc. Biol. 82: 1011–1018;
2007.
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INTRODUCTION
Mycobacteria are an important group of pathological microor-
ganisms causing disease in humans. Almost 2 billion people
are infected with Mycobacterium tuberculosis worldwide, and
more then 2 million people die each year as a result of
tuberculosis [1]. Other mycobacterial species, such as Myco-
bacterium leprae, are endemic in developing countries and are
responsible for high morbidity and invalidate many people [2].
In developed countries, the prevalence of infections with my-
cobacteria is increasing, especially in patients with a compro-
mised immune system. Under these circumstances, nonpatho-
genic mycobacteria may cause disease, such as Mycobacterium
avium complex (MAC) in HIV-infected patients.
Mycobacterium paratuberculosis is a member of the MAC,
which has been suggested to be associated with Crohn’s dis-
ease (CD), a chronic granulomatous inflammation of the gut.
This association is controversial, but some findings support a
causative role of M. paratuberculosis in the pathogenesis of CD
[3]. In cows, M. paratuberculosis causes Johne’s disease, which
is very similar to CD in humans [4]. Although M. paratuber-
culosis is not a known pathogenic for humans, it can be
cultured from intestinal biopsies of CD patients and even from
the blood [5, 6]. Furthermore, there is some evidence that
treatment of CD with antibiotics has a beneficial effect on the
disease activity [7, 8].
It is thought that the innate immune response contributes to
the difference in susceptibility to mycobacteria. The innate
immune system constitutes the first line of defense against
pathogens such as mycobacteria. The recognition of pathogen-
associated molecular patterns by pathogen recognition recep-
tors (PRR) is crucial for the initiation and coordination of this
response. The importance of these receptors is emphasized
further by the current concepts that the adaptive immune
response is partly under control of the innate immune system
[9, 10]. The extracellular TLR [11, 12] and C-type lectins [13,
14] are membrane-bound PRR, which are complemented by
the intracellular nucleotide-binding oligomerization domain-
like receptor (NLR) family [15, 16]. In animal models, it is well
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established that deficiencies of most of these receptors lead to
an impaired immune response against pathogens and a higher
susceptibility to infection [17].
Mutations in the LRR region of the nucleotide-binding oli-
gomerization domain 2 (NOD2) gene, a member of the NLR
family, are strongly associated with CD [18, 19]. NOD2 is
expressed in leukocytes and epithelial cells of the gastrointes-
tinal tract [20], and this intracellular receptor can recognize
peptidoglycans (PGNs) of Gram-positive and Gram-negative
bacteria [21]. Stimulation of NOD2 can induce production of
cytokines [22], chemokines [23], and defensins [24, 25]. All
these features suggest a key role for NOD2 in the innate
immune response of the gastrointestinal tract. Not only does
the intracellular PRR NOD2 seem to be important, but also,
recognition of the commensal microflora and pathogens by
extracellular TLRs in the gut is essential for the maintenance
of the intestinal homeostasis and involved in the development
of colitis [26]. Mutations in other genes of innate immunity
have also been reported to be associated with susceptibility to
CD [27, 28], which is considered to have a multifactorial
pathogenesis, and there is consensus that the interaction of the
innate immune system with the luminal bacterial flora is es-
sential for developing the chronic inflammation of the intestinal
mucosa [29]. However, it is still not clear whether pathogens,
such as M. paratuberculosis, may cause or perpetuate inflam-
mation in CD.
Despite the possible role of M. paratuberculosis in CD, there
is not much known about the interaction of M. paratuberculosis
and the innate immune system. A recent study has reported
association of live M. paratuberculosis in blood cultures and
biopsies with CD [6], and it has also been reported that CD
patients with mutations in the NOD2 gene are infected more
frequently with M. paratuberculosis than CD patients without
these mutations [30]. Recently, we have shown that TLRs and
NOD2 are nonredundant PRR of M. tuberculosis [31]. In the
present study, we further explore the receptors involved in the
recognition of the intracellular pathogen M. paratuberculosis.
By using animal and human in vitro models, we were able to
show that TLR2, TLR4, and NOD2 are involved in the recog-
nition of M. paratuberculosis.
MATERIALS AND METHODS
Reagents and microorganisms
Synthetic tripalmitoyl-S-glycero-Cys-(Lys)4 (Pam3Cys) was purchased from
EMC Microcollections (Tu¨bingen, Germany). Muramyl dipeptide (MDP) and
LPS (Escherichia coli serotype 055:B5) were purchased from Calbiochem (San
Diego, CA, USA) and Sigma Chemical Co. (St. Louis, MO, USA), respectively.
The synthetic MDP was tested for contamination with lipoproteins or LPS in
mice deficient in TLR2 or TLR4 (TLR2–/– or TLR4–/–, respectively), dem-
onstrating the absence of contamination. Diaminopimelic acid-containing mu-
ramyl tripeptide (M-TriDAP) was obtained as described previously [32]. As a
specific TLR4 antagonist, we used LPS derived from the cell membrane of the
Gram-negative bacterium Bartonella quintana, which has been demonstrated
to be a highly specific TLR4 antagonist [33].
Cultures of M. tuberculosis H37Rv and M. paratuberculosis were grown to
mid-log phase in Middlebrook 7H9 liquid medium supplemented with oleic
acid/albumin/dextrose/catalase (Difco Laboratories, Detroit, MI, USA), washed
three times in sterile saline, and resuspended in RPMI-1640 medium at the
various concentrations. Separate culture suspensions were washed three times
in sterile saline; subsequently, the bacteria were heat-killed and disrupted in
a bead-beater (Biospec Products, Bartlesville, OK, USA) using 0.1 mm glass
beads.
Genotyping of NOD2 variants
Blood was collected from 154 patients with CD and 10 healthy volunteers. PCR
amplification of NOD2 gene fragments containing the polymorphic site
3020insC was performed in 50 l reaction volumes containing 100–200 ng
genomic DNA as described previously [34]. The 3020insC polymorphism was
analyzed by Genescan analysis on an ABI-Prism 3100 genetic analyzer ac-
cording to the protocol of the manufacturer (Applied Biosystems, Nieuwerkerk,
The Netherlands).
Seven patients with CD were found homozygous for the 3020insC frameshift
mutation, and four of them were investigated further in the cytokine studies. As
control groups, five patients with CD bearing the wild-type alleles and five
healthy volunteers homozygous for the wild-type NOD2 allele were included.
Isolation of PBMC and stimulation of
cytokine production
After informed consent, venous blood was drawn from the cubital vein of
patients and healthy volunteers into three 10 ml EDTA tubes (Monoject,
s-Hertogenbosch, The Netherlands). Isolation of mononuclear cells (MNC) was
performed as described elsewhere [30] with minor modifications. The MNC
fraction was obtained by density centrifugation of blood diluted 1:1 in pyrogen-
free saline over Ficoll-Paque (Pharmacia Biotech AB, Uppsala, Sweden). Cells
were washed twice in saline and suspended in culture medium RPMI 1640,
supplemented with gentamicin 10 g/ml, L-glutamine 10 mM, and pyruvate 10
mM. The cells were counted in a Coulter counter (Coulter Electronics, Mij-
drecht, The Netherlands), and the number was adjusted to 5  106 cells/ml.
MNC (5105) in a 100-l vol were added to round-bottom, 96-well plates
(Greiner, Alphen a/d Rijn, The Netherlands) and incubated with 100 l
culture medium (negative control) or the various stimuli: M. tuberculosis
sonicate (10 g/ml), M. paratuberculosis sonicate (10 g/ml), MDP (100 nM),
LPS (10 ng/ml), or TLR4 antagonist (10 g/ml).
Cytokine production by murine
peritoneal macrophages
Resident peritoneal macrophages from TLR4/, TLR2/, MyD88/, or
control C57Bl/6N mice (kindly provided by Dr. Shizuo Akira, Research
Institute for Microbiological Diseases, Osaka University, Osaka, Japan) [35]
and LPS2 [Toll-IL-1R domain-containing adaptor-inducing IFN- (TRIF)-
defective] mice (kindly provided by Dr. Bruce Beutler, The Scripps Institute,
La Jolla, CA, USA) [36] were harvested by injection of 4 ml sterile PBS
containing 0.38% sodium citrate [37]. After centrifugation and washing, the
cells were resuspended in RPMI 1640 containing 1 mM pyruvate, 2 mM
L-glutamine, 100 g/ml gentamicin, and 2% fresh mouse plasma. Cells were
cultured in 96-well microtiter plates (Greiner, Alphen a/d Rijn) at 1  105
cells/well in a volume of 100 l. The cells were stimulated with purified LPS
(1 g/ml), Pam3Cys (1 g/ml), sonicate of M. tuberculosis (10 g/ml), or
sonicate of M. paratuberculosis (10 g/ml). After 24 h incubation at 37°C, the
supernatants were collected and stored at –70°C until cytokine assays were
performed.
Cytokine measurements
Murine TNF- and IL-1 concentrations were determined by specific radio-
immunoassays as described [33, 34]. Murine IL-10 and human IL-10 and
IL-1 were measured by commercial ELISA kits (Pelikine Compact, Sanquin,
Amsterdam, The Netherlands), according to the instructions of the manufac-
turer. Human TNF- concentrations were determined by specific ELISA [38].
Signaling through human TLR2 and TLR4 in
transfected cell lines
Chinese hamster ovary (CHO) fibroblasts stably transfected with human CD14
(3E10-CD14), a combination of CD14 and TLR2 (3E10-TLR2) or TLR4
1012 Journal of Leukocyte Biology Volume 82, October 2007 http://www.jleukbio.org
(3E10-TLR4), were a kind gift from Dr. Robin Ingalls (Boston Medical Center,
Boston University School of Medicine, Boston, MA, USA). Cell lines express
inducible membrane CD25 under control of a region from the human E-
selectin (endothelial leukocyte-adhesion molecule 1) promoter containing NF-
B-binding sites. Cells were maintained at 37°C and 5% CO2 in HAM’s F12
medium (Gibco, Invitrogen, Breda, the Netherlands), supplemented with 10%
FCS, 0.01% L-glutamine, 50 g/mL gentamicin and 400 U/mL hygromycin,
and 0.5 mg/mL G418 (for 3E10-TLR2) or 0.05 mg/mL puromycine (for
3E10-TLR4) as additional selection antibiotics. TLR2 and TLR4 expression
was confirmed by flow cytometry (Coulter Epics XL-MCL, Beckman Coulter,
Mijdrecht, the Netherlands) using PE-labeled anti-TLR2 (Clone TL2.1) or
anti-TLR4 (Clone HTA125; Immunosource, Halle-Zoersel, Belgium).
For stimulation experiments, 500 l cells in culture medium at a density of
1  105/mL were plated in 24-well culture plates. After an overnight incu-
bation, cells were incubated with control medium, M. tuberculosis sonicate (10
g/ml), M. paratuberculosis sonicate (10 g/ml), Pam3Cys (10 g/ml), or LPS
(1 g/ml) for 20 h, and thereafter, cells were harvested using trypsin/EDTA
(Cambrex, East Rutherford, NY, USA) and prepared for flow cytometry (Coulter
FACSscan). CD25 expression of the CHO cells was measured using FITC-
labeled anti-CD25 (Dako, Glostrup, Denmark) and expressed as a percentage
of CD25-positive cells.
Stimulation of NOD cell lines
and NF-B translocation
Studies examining the activation of NF-B by M. paratuberculosis sonicates in
cells overexpressing NOD1 or NOD2 were carried out as described previously
[19]. Briefly, human embryo kidney (HEK)293T cells were transfected over-
night with 1 ng NOD1 or NOD2 plus 75 ng luciferase reporter plasmid. At the
same time, sonicated, heat-killed M. paratuberculosis preparations were added
to cell culture medium, and the NF-B-dependent luciferase activation was
then measured following 24 h of incubation. NF-B-dependent luciferase
assays were performed in duplicate, and data represent three independent
experiments and expressed as a folds-over-mean increase.
Statistical analysis
The human experiments were performed in triplicate with blood obtained from
patients and volunteers. The mouse experiments were performed twice in 10
mice per group, and the data are presented as cumulative results of all
experiments performed. The differences between groups were analyzed by
Mann-Whitney U test or Wilcoxon and where appropriate, by Kruskal-Wallis
ANOVA test. The level of significance between groups was set at P  0.05.
The data are given as means  SEM.
RESULTS
M. paratuberculosis recognition by TLR2
and TLR4
To investigate the recognition of M. paratuberculosis by TLR2
and TLR4, both known to recognize M. tuberculosis, CHO cells
transfected with human TLRs were stimulated with sonicated
M. paratuberculosis. Whereas stimulation of CHO-TLR2 with
M. paratuberculosis resulted in a robust expression of the
reporter molecule CD25 (476%) as a measure of NF-B
activation (Fig. 1A), almost no expression of CD25 was seen
after stimulation of CHO-TLR4 (83%; Fig. 1B). To verify
these results in a more complex system, TLR knockout mice
were used. Indeed, peritoneal macrophages of TLR2/ mice
produced significantly less cytokines compared with control
mice after stimulation with M. paratuberculosis (Fig. 2). After
M. paratuberculosis stimulation, TLR4/ murine macro-
phages also produced significantly less cytokines than controls
(TNF-, Fig. 3A; IL-6, IL-10, and IL-1 also reduced, not
shown), although the difference was less pronounced, as seen
in the macrophages of TLR2/ mice. To further investigate
the role of TLR4 in the recognition of M. paratuberculosis,
human PBMC were stimulated with sonicated M. paratubercu-
losis in the presence and absence of anti-TLR4. Under these
conditions, the TNF- production after stimulation with LPS
was inhibited by over 50%, whereas no inhibitory effect on
TNF was seen when cells were stimulated with M. paratuber-
culosis (Fig. 3B). In addition, IL-1 production induced by M.
paratuberculosis was not influenced by TLR4 blockade (1255
pg/ml stimulation by M. paratuberculosis alone vs. 1860 pg/ml
by M. paratuberculosis in the presence of the TLR4 antagonist).
As heat-killing and sonication might influence the ability of M.
paratuberculosis to stimulate TLR4, we next stimulated human
PBMC with live M. paratuberculosis. Under these conditions,
the cytokine production was decreased significantly in the
presence of anti-TLR4 (Fig. 4). Thus, M. paratuberculosis is
recognized by TLR2 and TLR4.
As TLR2 and TLR4 are involved in the recognition of M.
paratuberculosis, MyD88 and TRIF knockout mice were used
to decipher which adaptor molecule is important for the cyto-
kine signal pathway. Stimulation of peritoneal macrophages of
MyD88/ mice with M. paratuberculosis resulted in signif-
icant, reduced cytokine production compared with control
Fig. 1. M. paratuberculosis stimulates TLR2-transfected CHO cells predom-
inantly and TLR4-transfected CHO cells modestly, and CHO cells cotrans-
fected with TLR2 and CD14 induced potent expression of CD25 on the cell
membrane as a measure for NF-B activation, after stimulation with a soni-
cated M. tuberculosis (MTB) or M. paratuberculosis (10 g/ml) measured by
FACS analysis (A). In contrast, cells transfected with CD14 and TLR4 were
hardly activated by M. tuberculosis or M. paratuberculosis (B). LPS (1 g/ml)
and Pam3Cys (5 g/ml) served as control stimuli for TLR4 and TLR2,
respectively. Experiments were performed twice.
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(Fig. 5A). Peritoneal macrophages of TRIF–/– mice stimulated
with M. paratuberculosis produced significantly less IL-1
compared with control cells, whereas there was no difference in
production of other cytokines (Fig. 5B). Thus, TLR signaling
after stimulation with M. paratuberculosis is mediated through
MyD88 and TRIF, although the MyD88-dependent pathway
seems to be more important.
M. paratuberculosis recognition of NOD1
and NOD2
To investigate the role of NOD1 and NOD2 in the recognition
of M. paratuberculosis, HEK293 cells transfected with human
NOD1 or NOD2 and a NF-B-driven, luciferase-reporter sys-
tem were stimulated with sonicated M. paratuberculosis.
NOD2-transfected cells responded in a dose-dependent NF-B
activation, expressed as fold-increase luciferase activity,
whereas NOD1-transfected cells responded marginally to high
concentrations of M. paratuberculosis (Fig. 6). To explore the
role of NOD2 recognition of M. paratuberculosis in human
cells, MNC of CD patients homozygous for the 3020insC frame-
shift mutation (NOD2fs), known to be nonfunctional, were
stimulated with sonicated M. paratuberculosis or a control
TLR2 ligand (the lipopeptide Pam3Cys). When stimulated with
Pam3Cys, TNF production was similar in cells isolated from
healthy volunteers (20255 pg/ml), CD patients with wild-type
NOD2 (21335 pg/ml), and CD patients homozygous for the
3020insC mutation (17553 pg/ml). After stimulation with M.
paratuberculosis, cytokine production of NOD2fs cells was less
than 30% of that by wild-type NOD2 allele (NOD2wt) and
controls (Fig. 7). Thus, NOD2 is involved in the M. paratu-
berculosis-induced cytokine production by human primary
PBMC.
DISCUSSION
In this study, we demonstrate that TLR2, TLR4, and NOD2 are
PRR for M. paratuberculosis, which are responsible for medi-
ating cytokine production and stimulation of host defense.
In the first part of the study, we show that murine and human
TLR2 recognize sonicated M. paratuberculosis. The role of
TLR2 for M. tuberculosis recognition was already established in
different experimental models [31, 39], and it is known that
Fig. 3. TLR4 involvement in M. paratuberculosis induced cytokine produc-
tion. Peritoneal macrophages of TLR4/ mice were stimulated with LPS (1
g/ml), sonicated M. tuberculosis (10 g/ml), or sonicated M. paratuberculosis
(10 g/ml). TNF- was measured in the supernatant by RIA after 24 h
incubation at 37°C. Groups of five mice/group were stimulated (A). Human
MNC of five healthy volunteers were stimulated with LPS (10 ng/ml), MTB (10
g/ml), or sonicated M. paratuberculosis (10 g/ml) in the presence or absence
of TLR4 antagonist. TNF- was measured in the supernatant by ELISA after
24 h incubation at 37°C (B). Data presented as mean  SEM and were
compared by Mann-Whitney U test (mice) and Wilcoxon paired test (human; *,
P0.05).
Fig. 2. TLR2 mediates recognition of M. paratuberculosis. Peritoneal macro-
phages of TLR2/ mice were stimulated with Pam3Cys (10 g/ml), soni-
cated M. tuberculosis (10 g/ml), or sonicated M. paratuberculosis (10 g/ml).
Cytokines TNF-, IL-1, and IL-10 were measured in the supernatant by
ELISA or radioimmunoassay (RIA) after 24 h incubation at 37°C. Groups of
five mice/group were stimulated. Data presented as mean  SEM and were
compared by Mann-Whitney U test (*, P0.05).
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19-kD lipoprotein of M. tuberculosis is recognized by TLR2
[40, 41]. Which structure of M. paratuberculosis engages TLR2
is yet unknown, but various immune-active lipoproteins, such
as19-kD lipoprotein [42], 22-kD lipoprotein [43], and 34-kD
lipoprotein [44, 45], have been identified in M. paratuberculo-
sis. It is therefore tempting to speculate that M. paratubercu-
losis lipoproteins may be recognized by TLR2.
The role of TLR4 in the recognition of mycobacteria is more
controversial. Sonicated M. tuberculosis has failed to stimulate
human TLR4 in various experimental models. Conversely, it
seems that TLR4 plays a beneficial role in tuberculosis infec-
tion models in mice [46, 47], although not all groups could
confirm these findings [48]. One remarkable aspect is that
TLR4 responds differently to intact compared with sonicated
mycobacteria [31], indicating that the sonication procedure
changes the structure of certain cell wall components, which
are important for TLR4 ligation. Our data show that TLR4 does
not play a role in the recognition of sonicated M. paratubercu-
losis in human PBMC and transfected CHO cells. However, the
role of TLR4 becomes apparent if human MNC are infected
with live M. paratuberculosis, as under these conditions, cyto-
kine responses were reduced by inhibition of TLR4. By con-
trast, macrophages from TLR4/ mice did produce less
TNF- after stimulation with sonicated M. paratuberculosis.
This finding indicates that there are differences between the
interaction of murine and human TLR4 with M. paratubercu-
losis. In addition, the interaction of leukocytes with compo-
nents of live M. paratuberculosis at the level of the cell mem-
brane is responsible for the TLR4-induced signaling. In con-
trast, NOD2 is an intracellular receptor, and recognition of M.
paratuberculosis by NOD2 most likely requires prior internal-
ization and digestion of the microorganism, leading to presen-
tation of NOD2-stimulating motifs, as is probably the case in
sonicated M. paratuberculosis. The structures of M. paratuber-
culosis responsible for interaction with human TLR4 are not
known, but data obtained with M. tuberculosis indicate that
structures sensitive for heat inactivation are responsible [39].
This might explain the different response after recognition of
sonicated and living M. paratuberculosis by human TLR4.
The intracellular signals induced by TLRs leading to cyto-
kine production are mediated by a limited number of adaptor
molecules [49]. For TLR4, there are two intracellular pathways
mediating its effects, represented by the adaptor molecules
MyD88 and TRIF, whereas TLR2 depends entirely on the
MyD88 pathway. We investigated which of the adaptor mole-
cules are involved in the TLR signaling induced by M. para-
tuberculosis. The data from MyD88/ and TRIF–/– mice
showed that MyD88 is important for the induction of TNF-,
IL-10, and IL-1, whereas TRIF only seems to be important for
Fig. 5. M. paratuberculosis induced cytokine production is TLR-adaptor
molecules MyD88- and TRIF-dependent. Peritoneal macrophages of
MyD88/ mice (	) or TRIF/ (
) were stimulated with sonicated M.
paratuberculosis (10 g/ml). Cytokines TNF-, IL-1, and IL-10 were mea-
sured in the supernatant by ELISA or RIA after 24 h incubation at 37°C.
Groups of six mice/group were stimulated. Data presented as mean  SEM and
compared by Mann-Whitney U test (*, P0.05).
Fig. 4. Live M. paratuberculosis stimulates TLR4 in human. Human MNC of
five healthy volunteers were stimulated with sonicated M. paratuberculosis (10
g/ml) or live M. paratuberculosis (107/ml) in the presence or absence of TLR4
antagonist. TNF- and IL-10 were measured in the supernatant by ELISA after
24 h incubation at 37°C. Data presented as mean  SEM and compared by
Wilcoxon paired test (*, P0.05).
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the induction of IL-1. This is in line with early studies
showing that TRIF is involved in the IL-1 production [50]. In
addition, TRIF-mediated signaling is associated mainly with
IFN- production.
NLRs are a class of intracellular receptors, which comple-
ment the extracellular TLRs. Among the NLRs, NOD1 and
NOD2 are the main receptors for PGN, and NOD1 recognizes
the PGN of Gram-negative bacteria, whereas NOD2 recognizes
the PGN of Gram-negative and Gram-positive bacteria. We
have shown recently that NOD2 is involved in the recognition
of M. tuberculosis and acts synergistically with TLR2 and TLR4
for the induction of cytokines [31]. When HEK cells trans-
fected with NOD2 were stimulated with sonicated M. paratu-
berculosis, a dose-dependent effect was observed, suggesting
that NOD2 recognizes M. paratuberculosis. In contrast, NOD1
only showed a marginal stimulation. We were able to confirm
this finding in human primary cells. The MNC of CD patients
homozygous for the 3020insC mutation, which are nonrespon-
sive for MDP [51], had a significant, reduced cytokine response
after stimulation with sonicated M. paratuberculosis. By soni-
cating M. paratuberculosis or during killing by macrophages,
fragments of the complete bacteria will be exposed and be able
to stimulate the different PRR. How small these components
are and how far they are degraded still remain unclear. For
stimulation of the intracellular receptors, these fragments have
to be taken up by leukocytes and digested further by enzymes
in the leukocytes before they can stimulate receptors such as
NOD2. The PGN of mycobacteria contains muramyl peptides
with the N-acetylglucosamine-N-glycolylmuramic acid back-
bone and the L-Ala-D-Glu-meso-DAP-D-Ala peptide side-
chain [52]. This muramyl peptide contains motifs, such as
L-Ala-D-Glu-meso-DAP (TriDAP), which can stimulate NOD1
[32]. Although it is known that the N-acetylmuramyl-L-Ala-D-
Glu (MDP) structure is the minimal motif to stimulate NOD2
[32], our data also suggest that a N-glycocylmuramic acid-
containing dipeptide can stimulate NOD2. As shown previ-
ously, the NOD2 3020insC mutation also leads to an impaired
cytokine production after stimulation of NOD1 in human pri-
mary cells, suggesting that NOD1 and NOD2 are needed for an
efficient response of the cells to NOD1 ligands [53]. Therefore,
the lack of functional NOD2 in Crohn’s patients with 3020insC
mutation may lead to defective responses to mycobacterial
PGNs, which contain strong NOD2-binding motifs but also
weaker NOD1 ligands. In conclusion, as M. paratuberculosis is
an intracellular pathogen, NOD2 might play an important role
in the defense against this mycobacterium.
In the present study, we describe for the first time the
receptors and mechanisms involved in the recognition of M.
paratuberculosis. TLRs, such as TLR2 and TLR4, as well as
NOD2 are independent recognition systems of M. paratuber-
culosis. It is tempting to speculate about the consequences of
the finding that M. paratuberculosis is recognized by NOD2, as
NOD2 polymorphism and M. paratuberculosis are associated
with CD. One might hypothesize that a defective recognition of
Fig. 6. NOD1 and NOD2 recognize M.
paratuberculosis in transfected HEK cells.
HEK293 cells with a luciferase reporter
construct (HEK-ctr) were transfected with
NOD1 (A) or NOD2 (B) and stimulated with
M. paratuberculosis. MDP (1 g/ml) and
TriDAP (1 g/ml) served as control stimuli
for NOD2 and NOD1, respectively. The NF-
B-dependent luciferase activation was
measured following 24 h of incubation. NF-
B-dependent luciferase assays were per-
formed in duplicate, and data represent
three independent experiments.
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M. paratuberculosis by cells of Crohn’s patients with NOD2
mutations is involved in the pathogenesis of CD.
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